Moderna (MRNA)

Cash & Equivalents

$1.72B

Quarterly · Period ending: · USD

MRNA logo

MRNA Cash & Equivalents

Latest reported$2.60B
MRNA FY Cash & Equivalents ($50.08M → $2.60B)
High-resolution chart · PNG

MRNA cash & equivalents history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna Cash & Equivalents — Annual fiscal periods (USD)
Period endingCash & Equivalents (USD)
2,595,000,000
1,927,000,000
2,907,000,000
3,205,000,000
6,848,000,000
2,624,000,000
235,876,000
658,364,000
134,859,000
50,080,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.